Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a potent antidiabetic agent with cardiorenal and weight-losing benefits in patients with type 2 diabetes (T2D). The combination of GLP-1 RA with basal insulin has been suggested in several clinical studies as a useful treatment for intensifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Hsuan-Wen, Cheng, Kai-Pi, Lin, An-Chi, Hung, Hao-Chang, Lin, Ching-Han, Wang, Chih-Chen, Wu, Hung-Tsung, Ou, Horng-Yih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787187/
https://www.ncbi.nlm.nih.gov/pubmed/36559020
http://dx.doi.org/10.3390/ph15121569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787187/
https://www.ncbi.nlm.nih.gov/pubmed/36559020
http://dx.doi.org/10.3390/ph15121569

Ejemplares similares